These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10195483)

  • 1. Emergency department management of occupational exposures to HIV-infected fluids.
    Torbati SS; Guss DA
    J Emerg Med; 1999; 17(2):261-4. PubMed ID: 10195483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: Emergency Department management of occupational exposures to HIV-infected fluids.
    Evans DW
    J Emerg Med; 2000 Jan; 18(1):121-2. PubMed ID: 10645851
    [No Abstract]   [Full Text] [Related]  

  • 3. New guidelines issued for occupational exposures.
    AIDS Policy Law; 1998 May; 13(10):10. PubMed ID: 11365445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group.
    Cardo DM; Culver DH; Ciesielski CA; Srivastava PU; Marcus R; Abiteboul D; Heptonstall J; Ippolito G; Lot F; McKibben PS; Bell DM
    N Engl J Med; 1997 Nov; 337(21):1485-90. PubMed ID: 9366579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. The CDC Cooperative Needlestick Surveillance Group.
    Tokars JI; Marcus R; Culver DH; Schable CA; McKibben PS; Bandea CI; Bell DM
    Ann Intern Med; 1993 Jun; 118(12):913-9. PubMed ID: 8387737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of zidovudine postexposure prophylaxis on the development of HIV-specific cytotoxic T-lymphocyte responses in HIV-exposed healthcare workers.
    D'Amico R; Pinto LA; Meyer P; Landay AL; Harris AA; Clerici M; Berzofsky JA; Shearer GM; Kessler HA
    Infect Control Hosp Epidemiol; 1999 Jun; 20(6):428-30. PubMed ID: 10395147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergency department management of blood and body fluid exposures.
    Moran GJ
    Ann Emerg Med; 2000 Jan; 35(1):47-62. PubMed ID: 10613940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Finding suggests AZT therapy may help prevent occupational HIV infection.
    AIDS Alert; 1995 Apr; 10(4):45-7. PubMed ID: 11362245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood--France, United Kingdom, and United States, January 1988-August 1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1995 Dec; 44(50):929-33. PubMed ID: 8531910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations for occupational exposures to HIV.
    Paul SM; Jorden V; Costa SJ; Ziskin LZ
    N J Med; 1999 Jan; 96(1):41-6. PubMed ID: 9949657
    [No Abstract]   [Full Text] [Related]  

  • 11. New recommendations for prophylaxis after HIV exposure.
    Perlmutter BL; Harris BR
    Am Fam Physician; 1997 Feb; 55(2):507-12, 515-7. PubMed ID: 9054220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic management of HIV/STD exposure.
    Moran GJ
    Emerg Med Clin North Am; 2000 Nov; 18(4):829-42, viii. PubMed ID: 11130941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDC wants more input before updating post-exposure guidelines. Centers for Disease Control and Prevention.
    AIDS Alert; 1996 Feb; 11(2):13-5. PubMed ID: 11363232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD; Holtgrave DR; Pinkerton HJ
    Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis.
    U.S. Public Health Service
    MMWR Recomm Rep; 2001 Jun; 50(RR-11):1-52. PubMed ID: 11442229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updated postexposure guidelines stress need for expert advice.
    AIDS Alert; 1998 Jul; 13(7):73-5. PubMed ID: 11365585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigations of possible failures of postexposure prophylaxis following occupational exposures to human immunodeficiency virus.
    Jochimsen EM; Luo CC; Beltrami JF; Respess RA; Schable CA; Cardo DM
    Arch Intern Med; 1999 Oct; 159(19):2361-3. PubMed ID: 10547177
    [No Abstract]   [Full Text] [Related]  

  • 18. Occupational exposure to HIV: considerations for postexposure prophylaxis and prevention.
    McClinsey SC
    Nurs Clin North Am; 1999 Mar; 34(1):213-25. PubMed ID: 9922288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medically compromised patients, Part II. Current trends in zidovudine chemoprophylaxis post HIV exposure.
    Mito RS; Wahlers M
    J Calif Dent Assoc; 1995 Nov; 23(11):27-31. PubMed ID: 9051999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 May; 47(RR-7):1-33. PubMed ID: 9603630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.